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Abstract
Previously, we reported that Lactobacillus rhamnosus CRL1505 peptidoglycan (PG05)
improves the innate immune response in immunocompromised-malnourished mice after
Streptococcus pneumoniae infection. This study extends those previous findings by demon-
strating that the dietary recovery of malnourished mice with nasal administration of PG05
improves not only the innate immune response but the respiratory and systemic adaptive
humoral response as well. PG05 enhanced the Th2 response, the recovery of B cells, and
the concentration and opsonophagocytic activity of anti-pneumococcal antibodies. In addi-
tion, by performing comparative studies with the peptidoglycans from lactobacilli of the
same species (L. rhamnosus CRL534) or with similar immunomodulatory properties (L.
plantarum CRL1506), we demonstrated here that PG05 has unique immunomodulatory
properties that cannot be extended to peptidoglycans from other probiotic strains. However,
the knowledge of the molecular characteristics of PG05 is indispensable to understand
immunomodulatory abilities of L. rhamnosus CRL1505.
Introduction
Probiotic microorganisms able to regulate the immune system (immunobiotics) are generally
selected from lactic acid bacteria (LAB) strains [1]. It is now well established that immunobio-
tics are capable to interact with the host’s immune and non-immune cells, and thereby impact
on mucosal and systemic immune responses [2–4]. It has been suggested that the final
response of the host to an immunobiotic bacteria depends on the combination of the different
bacterial molecules that can interact with the several receptors located in host´s cells [4]. More-
over, over the last years several molecules from immunobiotic bacteria have been associated to
the immunomodulatory effects and their beneficial impact on health including cell wall, pepti-
doglycan, exopolysaccharides and secreted metabolites [5–7].
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Lactobacillus rhamnosus CRL1505 is an immunobiotic strain that has been extensively stud-
ied by our laboratory because of its outstanding capacity to improve mucosal defenses in both
immunocompetent and immunocompromised hosts [2,3]. By using a mice model of immuno-
suppression associated to protein malnutrition, we demonstrated that malnourished hosts are
highly susceptible to respiratory pneumococcal infection [8,9]. The diminished resistance to
Streptococcus pneumoniae infection in malnourished mice was associated with multiple abnor-
malities of the immune system including alterations in emergency granulopoiesis, phagocyte
function, antibodies and cytokine production, B cell development, and CD4 Th2 cells numbers
and activities [8–12]. Of note, we found that the supplementation of balance conventional diet
(BCD) with nasally or orally administered L. rhamnosus CRL1505, during the recovery of mal-
nourished mice, was able to improve respiratory innate and humoral immune responses and
reduce the susceptibiltiy to pneumococcal infection [10,11,13]. While the viability of immuno-
biotic lactobacilli is an important factor to achieve optimal protective effects, it is possible to
stimulate immunity using non-viable immunobiotics [14,15]. Therefore, administration of
non-viable immunobiotics or their cellular components to beneficially modulate immune
responses represents an interesting and safe alternative specially in immunocompromised
hosts [16]. In this regard, we have reported that non-viable immunobiotics were effective in
the modulation of the respiratory and systemic immune system in malnourished hosts under
repletion treatments [14,15]. Moreover, we also found that the peptidoglycan was able to pre-
serve the immunomodulatory capacity of viable L. rhamnosus CRL1505, and was capable to
improve the resistance against pneumococcal infection in immunocompromised malnour-
ished mice by enhancing the recovery of the innate immune response [15].
We hypothesized that: a) the peptidoglycan of L. rhamnosus CRL1505 is as effective as
the viable strain for improving not only the innate but also the adaptive immune response
against S. pneumoniae in malnourished mice, and b) the immunomodulatory properties
of L. rhamnosus CRL1505 peptidoglycan in malnourished mice are specific and are not
common to peptidoglycans of other lactobacilli strains. Therefore, in this this work we
performed a comparative study to evaluate the effect of peptidoglycans from different lac-




L. rhamnosus CRL1505, L. plantarum CRL1506 and L. rhamnosus CRL534 were obtained from
the CERELA culture collection (Chacabuco 145, San Miguel de Tucuma´n, Argentina). The
cultures were kept freeze-dried and then rehydrated using the following medium: peptone
15.0 g, tryptone 10.0 g, meat extract 5.0 g, distilled water 1 l, pH 7. Lactobacilli were cultured
for 18 h at 37˚C (final log phase) in Man- Rogosa-Sharpe broth (MRS, Oxoid). Bacteria were
harvested by centrifugation at 3000 g for 10 min, washed three times with sterile 0.01 mol/l
phosphate buffer saline (PBS), pH 7.2, and resuspended in sterile on PBS. Peptidoglycans from
the three strains were obtained using the method of Shida et al. [17] with modifications, as we
previously described [15]. In all cases, the peptidoglycan preparations were free of contami-
nants such as lipoteichoic acid, wall teichoic acid and nucleic acid, as phosphorus was below
the level of detection (< 10 nmol/mg) in the preparation. We performed a study using Fourier
Transform Infrared Spectroscopy (FT-IR). The assignment of bands and the similarity exhib-
ited by the spectral profiles among them indicated that the samples would be peptidoglycans
isolated from lactic acid bacteria.
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Animals and feeding procedures
Male 3-week-old Swiss-albino mice were obtained from CERELA. Malnourished mice were
obtained from weaned mice that were were fed a protein-free diet (PFD) for 21 days as previ-
ously described [15]. Malnourished mice were divided in four groups for treatments: repletion
with a balanced conventional diet (BCD) during 7 days (BCD control group); repletion for
7 d with BCD and nasally adminsitered L. rhamnosus CRL1505 (PG05 group), L. plantarum
CRL1506 (PG06 group), or L. rhamnosus CRL534 (PG534 group) peptidoglycans in the last 2
days. Each peptidoglycan was administered in a dose of 8 μg/ml.
The doses of peptidoglycans were chosen on the basis of our previous results [15]. The com-
positions of the BCD and PFD diets were described previously [8]. Animal protocols were
approved by the Ethical Animal Protection Committee of CERELA-CONICET, Tucuma´n,
Argentina, under the protocol number BIOT-CRL-10, and all experiments comply with the
current laws of Argentina and all international organizations for the use of experimental
animals.
Streptococcus pneumoniae and pneumococcal infection
Streptococcus pneumoniae serotype 6B (one of the 10 most frequent serotypes isolated from
pneumococcal infections in Argentina) was isolated from the respiratory tract of a patient
from the Department of Bacteriology of Malbran Institute (Buenos Aires, Argentina). Seroty-
pification was carried out at the Administracio´n Nacional de Laboratorios e Institutos de
Salud (Buenos Aires, Argentina).
Challenge with S. pneumoniae was carried out at the end of each feeding procedure by
dropping 25 μL of the inoculum containing 109 log-phase cells of S. pneumoniae in PBS into
each nostril and involuntarily inhaled [15]. To facilitate migration of the inoculum to the alve-
oli, mice were held in a vertical position for 2 min. Animals were sacrificed at day 0 (before
challenge) and at different days post-infection.
Bacterial cell counts in lung and blood
For the evaluation of S. pneumoniae infection, lungs were excised, weighed and homogenized
in 5 ml of sterile 0.1% peptone water. Homogenates were diluted appropriately, plated in
duplicate on blood agar and incubated 18 h at 37˚C. The results were expressed as log of CFU/
g lung. Progression of bacterial growth into the bloodstream was monitored by sampling
blood obtained through cardiac puncture and plating on blood agar. Results were reported as
log of CFU/ml [15].
Lung injury
For the evaluation of pulmonary tissue injuries, lungs were excised, washed out with PBS,
and immersed in 4% (v/v) formalin saline solution for the histologycal study as previously
mentioned [15]. In addition, biochemical parameters as albumin content and lactate dehy-
drogenase (LDH) activity were studied in broncho-alveolar lavages (BAL). Albumin content
was determined colorimetrically based on albumin binding to bromocresol green using an
albumin diagnostic kit (Wiener Lab). LDH activity was determined by measuring the for-
mation of the reduced form of nicotinamide adenine dinucleotide using the Wiener
reagents and procedures (Wiener Lab), and was expressed as units per liter of BAL fluid
[18].
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Leukocyte counts in blood and BAL
Blood samples were obtained by cardiac puncture at the end of each treatment and collected in
heparinized tubes. BAL samples were obtained as described previously [15]. Briefly, the trachea
was exposed surgically and intubated with a catheter. A small incision was made in the trachea
and two sequential bronchoalveolar lavages were performed in each mouse by injecting sterile
PBS with 1% heparin. The recovered fluid was centrifuged for 10 min at 300 rpm. The pellet
was used to perform the leukocyte count following the conventional hematological methodol-
ogy. Total number of blood and BAL leukocytes was determined with a hemocytometer. Dif-
ferential cell counts were performed by counting 200 cells in blood and BAL smears stained
with May-Gru¨nwald Giemsa using a light microscope (1000×), and absolute cell numbers
were calculated [19].
Myeloperoxidase activity of neutrophils
Measurement of myeloperoxidase (MPO) activity of blood neutrophils was carried out by the
use of the Washburn test, which is a cytochemical method that uses benzidine as an MPO
chromogen [9]. Cells were graded as negative or weak, moderate, or strongly positive accord-
ing to the intensity of reaction and were used to calculate the score. The score was calculated
by counting 200 neutrophils in blood smears. The score value was calculated by the addition of
neutrophils with different positive grades.
Cytokines and antibodies in serum and BAL
Tumour necrosis factor (TNF)-α, interleukin (IL)-10, IL-2, IL-4, and Interferon (INF)-γ were
measured in serum and BAL samples at days 2 and/or 10 post-infection by using commercially
available enzyme-linked immunosorbent assay (ELISA) technique kits, following the manufac-
turer’s recommendations (ELISPOT Ready-SET-Go!1, eBioscience, San Diego, USA). Anti-
pneumococcal antibodies (IgA, IgM, and IgG) were determined by ELISA on day 10 post-
infection as previoulsy described [8]. In brief, plates were coated with a 1:100 dilution of heat-
killed S. pneumoniae overnight at 4˚C and blocked with PBS containing 5% non-fat dry milk.
Appropriate dilutions of the samples (serum 1:20; BAL 1:2) were incubated for 1 h at 37˚C.
Peroxidase conjugated anti-mouse IgG, IgA, or IgM (1:500) (Sigma- Aldrich) were added and
incubated for 1 h at 37˚C. The reaction was developed with TMB Substrate Reagent (Sigma-
Aldrich). The concentration was measured with reference to standard curves using known
amounts of the respective murine Immunoglobulin (Sigma-Aldrich).
Opsonophagocytic activity
Heat-killed pneumococci were incubated with FITC (Fluorescein 5(6)-isothiocyanate, Sigma-
Aldrich) (15 ug/ml) for 30 min at 37˚C), and then washed three times with PBS buffer (pH
7.4). The opsonophagocytic activity of BAL and serum antibodies was determined by measur-
ing the phagocytosis of FITC-labeled pneumococci by peritoneal macrophages. For this pur-
pose, FITC-labeled S. pneumoniae was incubated with BAL or serum samples at 37˚C for 30
min. The opsonization mix was the added to 106 macrophages/ml (macrophage/bacteria ratio
of 1/100) and incubated for 30 min. Phagocytosis was measured by flow cytometry. The exter-
nal fluorescence was blocked with the addition of trypan blue to the cell suspensions. The dif-
ference between blocked and non-blocked samples was calculated and represented in MFI
graph [20,21].
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Flow cytometry studies
Single cell suspensions of spleen, thymus and lung were prepared according to Barbieri et al.
[10]. Lungs were removed, incubated for 60 min with 300 U of Type I collagenase (Sigma-
Aldrich) in 3 ml of RPMI 1640 medium (Sigma-Aldrich) and then minced into small pieces.
To dissociate the tissue into single cells, collagenase-treated minced lungs were gently tapped
into a plastic dish. After removal of debris, erythrocytes were depleted by hypotonic lysis
(Tris-ammonium chloride, BD PharMingen). The cells were washed and resuspended in
RPMI supplemented with 4% heat-inactivated foetal calf serum (FCS). Spleens and thymus
were collected and tissue was homogenized through a tissue strainer with PBS 1% FCS, fol-
lowed by incubation with lysis buffer to eliminate erythrocytes [22]. Bone marrow cells were
obtained by flushing femurs of mice using cold PBS 1% FCS. Cell suspensions were centri-
fuged 4 min at 2500 rpm at 4˚C, and incubated with lysis buffer to eliminate erythrocytes [22].
Cell viability was assessed by Trypan blue exclusion. Cells were kept on ice until immunofluo-
rescence labeling.
The following antibodies from BD PharMingen were used: FITC labeled anti-mouse-CD3,
biotinylated anti-mouse-CD4, PE labeled anti-mouse-CD8, FITC labeled anti-mouse-CD11c,
PE labeled anti-mouse-MHCII, APC labeled anti-mouse- CD45, PE labeled anti-mouse-Gr-1,
APC labeled anti-mouse-F4/80, FITC labeled anti-mouse-CD25, biotinylated anti-mouse-
TCRαβ, biotinylated anti-mouse-B220, FITC labeled anti-mouse-IgM, and biotinylated anti-
mouse-IgD antibodies. Following incubation with biotinylated primary antibodies, the label-
ing was revealed using streptavidin-PercP. In all cases, cells were acquired on a BD FACSCali-
bur™ flow cytometer (BD Biosciences) and data was analyzed with FlowJo software (TreeStar).
The total number of cells in each population was determined by multiplying the percentages of
subsets within a series of negative markers or positive gates by the total cell number deter-
mined for each tissue.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 6.0 software. Experiments were per-
formed in triplicate and the results were expressed as mean ± standard deviation (SD). After
verification of the normal distribution of data, 2-way ANOVA was used. Tukey’s test (for pair-
wise comparisons of the means) was used to test the differences between the groups. Differ-
ences were considered significant at p<0.05, p<0.01, or p<0.001.
Results
Effect of lactobacilli peptidoglycans on the resistance to pneumococcal
infection in malnourished mice
In previous reports we demonstrated that malnourished mice have an increased susceptibility
to pneumococcal infection [8,9] and that the repletion with BCD supplemented with nasally
administered PG05 significantly increase the resistance against the respiratory pathogen [15].
In this work, we first aimed to investigate whether the peptidoglycans obtained from different
lactobacilli strains were able to induce a similar effect. Therefore, we comparatively studied the
effect of PG05 and peptidoglycans from L. plantarum CRL1506 (PG06, immunomodulatory
strain), and L. rhamnosus CRL534 (PG534, non-immunomodulatory strain). As we previously
observed, repletion of malnourished mice with BCD supplemented with the nasal administra-
tion of PG05 allowed the elimination of the pathogen since it was not detected in lung or
blood (Table 1). On the contrary, PG06 and PG534 treatments failed to induce this effect since
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pneumococcal cell counts in lungs and blood were similar to those observed in the BCD con-
trol group (Table 1).
We also evaluated lung tissue injury by performing histological studies and determining
BAL albumin content, a measure of the bronchoalveolar–capillarity barrier permeability, and
BAL LDH activity, an indicator of general cytotoxicity (Fig 1). The infectious challenge with S.
pneumoniae induced a moderate infiltration of inflammatory cells in the lungs of BCD and
BCD+PG06 groups. BCD+PG534 group showed a prominent infiltration of inflammatory
cells into the lung parenchyma. In addition, a preserved lung parenchyma and reduced cell
infiltration was observed in BCD+PG05 group (Fig 1A). Levels of both LDH and albumin in
BAL were higher in BCD, BCD+PG06, and BCD+PG534 groups when compared to those
observed for the BCD+PG05 treatment (Fig 1B).
Effect of lactobacilli peptidoglycans on the innate immune response to
pneumococcal infection in malnourished mice
We next studied the effect of the different peptidoglycans on the respiratory and systemic
innate immune response by evaluating the number of lung and blood leukocytes and the levels
of respiratory and systemic cytokines. As we reported previously [15], the challenge with S.
pneumoniae significantly increased the number of BAL leucocytes in all the experimental
groups (Fig 2A–2C). However, levels of BAL leucocytes (Fig 2A), macrophages (Fig 2B), and
neutrophils (Fig 2C) were significantly higher in BCD+PG05-treated mice than in the other
groups. In fact, values of BAL leucocytes in BCD+PG06 and BCD+PG534 were not statistically
different from those in the BCD group. In order to confirm these results, we further evaluate
lung phagocytes populations by flow cytometry. As shown in Fig 2D, the number of
CD11c+F4/80+MHCII+ macrophages was significantly higher in BCD+PG05-treated mice
than in the other experimental groups. The numbers of lung CD45+Gr1+ and CD45+Gr1high
neutrophils was higher in BCD+PG05 than in BCD and BCD+PG534 groups (Fig 2E). Inter-
estingly, lung CD45+Gr1+ and CD45+Gr1low neutrophils in the BCD+PG06 group were no sta-
tistically different from BCD+PG05.
When we evaluated blood leucocytes, we found that infection increased the numbers of
blood leucocytes (Fig 3A) and neutrophils (Fig 3B) as well as blood peroxidase activity (Fig
3C) in all the experimental groups. The number of blood leucocytes in BCD and BCD+PG534
groups were higher than in BCD+PG05, while no differences were observed with BCD+PG06.
Taking into consideration that activated neutrophils show a high peroxidase activity in their
Table 1. Resistance to pneumococcal infection.
Lung Blood
BCD 4.47± 0.05  5.15± 0.10 
BCD+PG05 < 1.5 < 1.5
BCD+PG06 4.47± 0.08  5.14± 0.12 
BCD+PG534 4.62± 0.08  5.28± 0.04 
Malnourished mice were replete for 7 days with a balanced conventional diet (BCD) or BCD supplemented with
nasal administration of peptidoglycans from Lactobacillus rhamnosus CRL1505 (BCD+PG05), Lactobacillus
plantarum CRL1506 (BCD+PG06) or Lactobacillus rhamnosus CRL534 (BCD+PG534), and then challenged with S.
pneumoniae. Bacterial cell counts in lung (log CFU/g of lung) and blood (CFU/ ml) after challenge. Data are for six
individual mice per group. Results represent data from three independent experiments. Results are expressed as
mean ± SD. Asterisks represent statistical differences compared with BCD+PG05 group.
 p  0.001.
https://doi.org/10.1371/journal.pone.0194034.t001
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granules [23], we decided to study peroxidase positive cells at day two post-infection. While
the numbers of neutrophils from the studied groups were not significantly different between
them (Fig 3B), the peroxidase activity of those immune cells was significantly higher in BCD+-
PG05-treated mice when compared to the other experimental groups (Fig 3C).
Spleen macrophages contribute significantly to early protection against bacterial dissemina-
tion [24]. Then we also evaluated the numbers of macrophages in spleen that were defined as
CD11c+F4/80+MHCII+ cells. Results showed that spleen macrophages were significantly
higher in BCD+PG05-treated mice than in the other groups (Fig 3D).
Fig 1. Effect of lactobacilli peptidoglycans on lung injuries induced by the infection of Streptococcus pneumoniae
in malnourished mice. Immunocompromised-malnourished mice were replete for 7 days with a balanced
conventional diet (BCD) or BCD supplemented with peptidoglycans from Lactobacillus rhamnosus CRL1505 (BCD
+PG05), L. plantarum CRL1506 (BCD+PG06) or L. rhamnosus CRL534 (BCD+PG534), and then challenged with S.
pneumoniae. Two days after pneumococcal challenge, lung damage was evaluated by histological studies and
biochemical parameters. (A) Lungs histological examination. Hematoxylin and eosin stained light micrographs,
original magnification ×100. Recruited inflammatory cells (RIC), reduction of alveolar airspaces (RAA), moderate
inflammatory response (MIR), conserved alveolar air spaces (CAA). (B) Lactate dehydrogenase (LDH) activity and,
albumin concentration in broncho-alveolar lavages (BAL). The results represent data from three independent
experiments. Results are expressed as mean ± SD. Asterisks represent statistical differences compared with the BCD
+PG05 group.  p< 0.005,  p 0.001.
https://doi.org/10.1371/journal.pone.0194034.g001
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Fig 2. Effect of lactobacilli peptidoglycans on the respiratory innate immune response to Streptococcus pneumoniae infection in
malnourished mice. Immunocompromised-malnourished mice were replete for 7 days with a balanced conventional diet (BCD) or BCD
supplemented with peptidoglycans from Lactobacillus rhamnosus CRL1505 (BCD+PG05), L. plantarum CRL1506 (BCD+PG06) or L.
rhamnosus CRL534 (BCD+PG534), and then challenged with S. pneumoniae. The respiratory innate immune response was studied two days
after the pneumococcal challenge. (A) Number of broncho-alveolar lavages (BAL) leukocytes. (B) Number of BAL macrophages. (C)
Number of BAL neutrophils. (D) Number of lung macrophages (CD11c+F480+MHCII+). (E) Number of lung neutrophils (CD45
+Gr1+).
Results represent data from three independent experiments. Results are expressed as mean ± SD. Asterisks represent statistical differences
compared with BCD+PG05 group.  p< 0.05,  p 0.001, / p 0.001.
https://doi.org/10.1371/journal.pone.0194034.g002
Fig 3. Effect of lactobacilli peptidoglycans on the systemic innate immune response to Streptococcus pneumoniae infection in malnourished mice.
Immunocompromised-malnourished mice were replete for 7 days with a balanced conventional diet (BCD) or BCD supplemented with peptidoglycans
from Lactobacillus rhamnosus CRL1505 (BCD+PG05), L. plantarum CRL1506 (BCD+PG06) or L. rhamnosus CRL534 (BCD+PG534), and then
challenged with S. pneumoniae. The systemic innate immune response was studied two days after the pneumococcal challenge. (A) Number of blood
leukocytes. (B) Number of blood neutrophils. (C) Score of blood peroxidase. (D) Number of spleen macrophages (CD11c+F480+MHCII+). Results
represent data from three independent experiments. Results are expressed as mean ± SD. Asterisks represent statistical differences compared with BCD
+PG05 group.  p< 0.05,  p< 0.005, / p 0.001.
https://doi.org/10.1371/journal.pone.0194034.g003
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In addition, relevant cytokines involved in the innate immune response against S. pneumo-
niae were measured on BAL and blood (Fig 4). Levels of both TNF-α and IL-10 were increased
after the challenge with S. pneumoniae in BAL and blood. BCD+PG05 group showed the high-
est values of BAL and blood IL-10 (Fig 4B and 4E) and the lowest TNF-α/IL-10 ratio (Fig 4C
and 4F) when compared with the others experimental groups. Conversely, the BCD+PG534
group exhibited significant higher levels of BAL and blood TNF-α that the other groups (Fig
4A and 4D), while BCD+PG06 was not different from the BCD group.
Effect of lactobacilli peptidoglycans on T cells immune response against
pneumococcal infection in malnourished mice
Considering that the efficient clearance of S. pneumoniae depends on both cellular and
humoral immunity, we evaluate the effect of peptidoglycans treatments on the number and
function of effector cells and mediators of adaptive immune response against to this respira-
tory pathogen. Different populations of T cells were analyzed in lung, spleen, and thymus (Fig
5) at day 10 post-infection by flow cytometry. Lung lymphocytes were significantly higher in
BCD+PG05-treated mice when compared with the other experimental groups (Fig 5A). In
particular, increased numbers of lung CD3+CD4+ T cells were observed in BCD+PG05-
treated animals when compared with BCD and BCD+PG06 groups. BCD control group
showed lower values of CD3+CD8+ T cells compared with BCD+PG05 mice (Fig 5B). Worthy
of note, although the total number of lung lymphocytes in BCD+PG534 group were different
Fig 4. Effect of lactobacilli peptidoglycans on TNF-α and IL-10 production after Streptococcus pneumoniae infection in malnourished mice.
Immunocompromised-malnourished mice were replete for 7 days with a balanced conventional diet (BCD) or BCD supplemented with peptidoglycans from
Lactobacillus rhamnosus CRL1505 (BCD+PG05), L. plantarum CRL1506 (BCD+PG06) or L. rhamnosus CRL534 (BCD+PG534), and then challenged with S.
pneumoniae. The levels of cytokines were studied two days after the pneumococcal challenge. (A) TNF-α, (B) IL-10, and (C) TNF-α/IL-10 ratio in broncho-alveolar
lavages (BAL). (D) TNF-α, (E) IL-10, and (F) TNF-α/IL-10 ratio in serum. Results are expressed as mean ± SD. Asterisks represent statistical differences compared with
BCD+PG05 group.  p< 0.05,  p< 0.005, / p 0.001.
https://doi.org/10.1371/journal.pone.0194034.g004
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from BCD+PG05 mice, lung CD3+CD4+ and CD3+CD8+ T cells reached the values of the
BCD+PG05 group. In addition, it was observed that spleen CD3+CD4+ T cells were signifi-
cantly higher in BCD+PG05-treated mice when compared with the other experimental groups
while no differences were found in spleen CD3+CD8+ T cells (Fig 5C and 5D).
When the total number of lymphocytes and the different subpopulation of T cells were eval-
uated in the thymus, we observed that BCD+PG05 mice had significantly higher numbers of
total lymphocytes (Fig 5E) as well as double negative (DN) CD3-CD4-CD8-CD25+, double
positive (DP) CD4+CD8+CD3low (immature cells) (Fig 5F), and simple positive (SP) CD3+
CD4+ T cells that the other experimental groups (Fig 5G). SP CD3+CD8+ T cells (Fig 5G) in
BCD+PG05 were not different from BCD mice. However, levels of SP CD3+CD8+ T cells in
the thymus of BCD+PG06 and BCD+PG534 were lower than the BCD+PG05 group (Fig 5G).
In addition, it was observed that CD3highTCRαβ+ cells were higher in mice treated with BCD
plus peptidoglycans when compared to those in the BCD group.
We also evaluated Th1 and Th2 cytokines profiles in respiratory and systemic compart-
ments at day 10 after challenge with S. pneumoniae. Levels of BAL and serum IFN-γ, IL-2, IL-4
and IL-10 increased significantly in all the experimental groups after challenge. However, BAL
IFN-γ production was lower in groups treated with BCD plus peptidoglycans (Fig 6A), while
serum IFN-γ did not show statistical differences between groups (Fig 6B). Levels of BAL and
serum IL-2 were significantly higher in BCD+PG05-treated mice when compared with the
other experimental groups (Fig 6B and 6F). In addition, repletion of malnourished mice with
BCD+PG05 significantly improved the production of BAL and serum IL-4 and IL-10, which
showed higher levels than those of the BCD control group (Fig 6C, 6D, 6G and 6H). Levels of
these two cytokines in BCD+PG06-treated mice were not different from the BCD group, while
serum IL-10 in BCD+PG534 mice was significantly lower when compared to the other experi-
mental groups (Fig 6D and 6H).
Effect of lactobacilli peptidoglycans on humoral immune response against
pneumococcal infection in malnourished mice
We studied the humoral immune response to pneumococcal infection by evaluating B cells in dif-
ferent organs and the levels and activity of specific antibodies. The analysis of B cells on distinct
maturation states was performed on day 15 post-infection (Fig 7). We observed that BCD+PG05
mice showed higher values of lung total lymphocytes compared with the other groups (Fig 5A). In
addition, BCD+PG05 group showed significantly increased numbers of B220lowCD19+CD24high
immature, B220highCD19+CD24low (Fig 7A), and IgD+IgM-CD24low mature B cells (Fig 7B) in
lungs when compared to the other experimental groups (Fig 9A). B220highCD19+CD24low and
IgD+IgM+/-CD24low mature B cells in spleen were also higher in BCD+PG05-treated mice than in
the other groups (Fig 7C and 7D).
In addition, we evaluated B cells populations in bone marrow. Bone marrow total lymphocytes
in BCD+PG05 mice were higher than the other experimental groups. In addition, BCD+PG05
group exhibited an increase of B220lowIgM-CD24high pro-pre (Fig 7E), and IgD-IgM+CD24high
Fig 5. Effect of lactobacilli peptidoglycans on lung, spleen and thymus T cells numbers after Streptococcus pneumoniae
infection in malnourished mice. Immunocompromised-malnourished mice were replete for 7 days with a balanced
conventional diet (BCD) or BCD supplemented with peptidoglycans from Lactobacillus rhamnosus CRL1505 (BCD+PG05), L.
plantarum CRL1506 (BCD+PG06) or L. rhamnosus CRL534 (BCD+PG534), and then challenged with S. pneumoniae. The
numbers of T cells were studied ten days after the pneumococcal challenge. (A) Number of total lymphocytes in lung. (B)
Number of CD3+CD4+ and CD3+CD8+ T cells in lung. (C) Number of total lymphocytes in spleen. (D) Number of
CD3+CD4+ and CD3+CD8+ T cells in spleen. (E) Number of total lymphocytes in thymus. (F) CD4-CD8-CD25+ and
CD4+CD8+CD3low (immature cells). (G) CD3+CD4+ and CD3+CD8+ (mature cells). Results are expressed as mean ± SD.
Asterisks represent statistical differences compared with BCD+PG05 group.  p< 0.05, p< 0.005, / p 0.001.
https://doi.org/10.1371/journal.pone.0194034.g005
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immature (Fig F) B cells when these cells were compared with the BCD, BCD+PG06 and BCD
+PG534 groups. B220highIgM+CD24low and IgD+IgM+CD24low mature B cells in BCD+-
PG05-treated mice were also significantly higher than those observed in the other groups (Fig 7E
and 7F).
Finally, we determined the levels of anti-pneumococcal antibodies in serum and BAL (Fig
8). Concentrations of specific IgA, IgG, and IgM in both serum and BAL were significantly
higher in mice that received PG05 when compared to the BCD group. BAL and serum IgA
and IgM antibodies in BCD+PG06-treated mice were not different from the BCD group, while
BAL IgG levels were similar to those observed in the BCD+PG05 group (Fig 8). In addition, all
the studied antibodies in the BCD+PG534 group were similar to BCD mice (Fig 8). We also
evaluated the opsonophagocytic activity of serum anti-pneumococcal antibodies of each group
of mice, and found that the capacity of antibodies from BCD+PG05 mice to increase the
phagocytosis of heat-killed pneumococci was significantly higher when compared to the other
experimental groups (Fig 9).
Discussion
In recent years, there have been substantial advances in the knowledge of the molecular cross-
talk between beneficial microbes and the mucosal immune system through the identification
of bacterial molecules and hosts receptors involved in immunomodulation. In this regard, L.
rhamnosus CRL1505 is an immunobiotic strain that is used as a probiotic specially directed to
children [25], and has been widely characterized by our laboratory [10–13,15,22,26]. Our stud-
ies have demonstrated that the supplementation of BCD with nasally administered viable
CRL1505 strain, during the recovery of malnourished mice, allows an improvement of the
respiratory immune response and emergency granulopoiesis [10–12].
Of note, the use of molecules from beneficial microbes could be an interesting alternative to
stimulate immunity in immunocompromised hosts, in which viable microorganisms could
involve a health risk [27]. In this regard, we have identified that the peptidoglycan is an
Fig 6. Effect of lactobacilli peptidoglycans on Th1 and Th2 cytokines production after Streptococcus pneumoniae infection in malnourished mice.
Immunocompromised-malnourished mice were replete for 7 days with a balanced conventional diet (BCD) or BCD supplemented with peptidoglycans from
Lactobacillus rhamnosus CRL1505 (BCD+PG05), L. plantarum CRL1506 (BCD+PG06) or L. rhamnosus CRL534 (BCD+PG534), and then challenged with S.
pneumoniae. The levels of cytokines were studied ten days after the pneumococcal challenge. (A-D) Broncho-alveolar lavages (BAL), and (E-H) serum concentration of
INF-γ, IL-2, IL-4, and IL-10. Results represent data from three independent experiments. Results are expressed as mean ± SD. Asterisks represent statistical differences
compared with BCD+PG05 group.  p< 0.05,  p< 0.005, / p 0.001.
https://doi.org/10.1371/journal.pone.0194034.g006
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Fig 7. Effect of lactobacilli peptidoglycans on lung, spleen and bone marrow (BM) B cells numbers after Streptococcus pneumoniae
infection in malnourished mice. Immunocompromised-malnourished mice were replete for 7 days with a balanced conventional diet (BCD)
or BCD supplemented with peptidoglycans from Lactobacillus rhamnosus CRL1505 (BCD+PG05), L. plantarum CRL1506 (BCD+PG06) or
L. rhamnosus CRL534 (BCD+PG534), and then challenged with S. pneumoniae. The numbers of B cells were studied fifteen days after the
pneumococcal challenge. Different lung B cells subpopulations: (A) B220lowCD19+CD24high (immature cells) and B220highCD19+CD24low
(mature cells) (B) IgD+IgM-CD24low (mature cells) Different spleen B cells subpopulations: (C) B220lowCD19+CD24high (immature cells) and
B220highCD19+CD24low (mature cells). (D) IgD+IgM+CD24low (immature cells) and IgD+IgM-CD24low (mature cells). Different B cells
subpopulations in BM: (E) B220lowIgM-CD24high pre-pro B cells and B220highIgM+CD24low mature B cells. (F) IgD-IgM+CD24high immature
B cells and IgD+IgM+CD24low mature B cells. Results represent data from three independent experiments. Results are expressed as
mean ± SD. Asterisks represent statistical differences compared with BCD+PG05 group.  p< 0.05,  p< 0.005, / p 0.001.
https://doi.org/10.1371/journal.pone.0194034.g007
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important bacterial component for the immunomodulatory activities of L. rhamnosus
CRL1505 and we have focused our attention on the immunomodulatory effect of this peptido-
glycan in immunocompromised hosts. Of interest, we have shown that PG05 was as effective
as the viable bacteria for improving systemic and respiratory innate immune responses during
recovery of immunocompromised-malnourished mice [15]. Here, we have further advanced
in the study of PG05 by evaluating whether its immunoregulatory activity is a strain specific
property. We performed comparative studies to evaluate the effect of peptidoglycans from dif-
ferent lactobacilli on the innate and adaptive immune responses to pneumococcal infection in
malnourished mice. We demonstrated that PG05 has unique immunomodulatory capacities
that cannot be extrapolated to peptidoglycans from other lactobacilli of the same species or lac-
tobacilli with immunomodulatory properties.
We clearly demonstrated that PG05, nasally administered during the repletion treatment of
malnourished mice, was the only peptidoglycan able to increase the resistance against S. pneu-
moniae infection, which was demonstrated by the lower lung pathogen counts accompanied
by reduced lung damage. These results are in line with previous work [15]. Nevertheless, this
effect was not observed in the animals that received PGs extracted from L. rhamnosus CRL534,
a non-probiotic strain [28], or L. plantarum CRL1506, whose nasal administration modulates
the antiviral immune response in the lung [29]. To explain the differences in the immunomod-
ulatory activities of the studied PGs one important point should be considered. It is a well-
established fact that the immunomodulatory properties of probiotic bacteria are strain specific.
Fig 8. Effect of lactobacilli peptidoglycans on anti-pneumococcal antibodies levels after Streptococcus pneumoniae infection in malnourished mice.
Immunocompromised-malnourished mice were replete for 7 days with a balanced conventional diet (BCD) or BCD supplemented with peptidoglycans from
Lactobacillus rhamnosus CRL1505 (BCD+PG05), L. plantarum CRL1506 (BCD+PG06) or L. rhamnosus CRL534 (BCD+PG534), and then challenged with S.
pneumoniae. The levels of antibodies were studied fifteen days after the pneumococcal challenge. (A) Levels of anti-peumococcal IgA, (B) IgG and (C) IgM in broncho-
alveolar lavages. (D) Levels of anti-peumococcal IgA, (E) IgG and (F) IgM in serum. Results represent data from three independent experiments. Results are expressed as
mean ± SD. Asterisks represent statistical differences compared with BCD+PG05 group.  p< 0.05, p< 0.005, / p 0.001.
https://doi.org/10.1371/journal.pone.0194034.g008
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In this sense, several examples can be found in scientific published works regarding this state-
ment for immunobiotic lactobacilli [30,31]. However, the PG may be one of the different bac-
terial molecules associated to their beneficial effects. Thus, our studies were conducted to
elucidate the immunological mechanisms that allow us to understand the different effects of
PGs under study.
It is known that during lung infections such as those produced by S. pneumoniae, phago-
cytic cells are key in host defense [32,33]. When the bacterial inoculum increases above the
level at which alveolar macrophages can contain bacteria without recruitment of further
phagocytes, cross-talk between macrophages, epithelial cells and T cells results in the release of
chemokines and recruitment of further leukocytes, particularly polymorphonuclear cells.
These cells become critical effectors of bacterial clearance [34]. For this reason, the low num-
ber of lung phagocytic cells in malnourished mice could be related to impaired host defenses,
which would explain their difficulties to eradicate the pathogens from the lungs as we showed
previously [10,11]. Our previous studies [15] and the present results showed that PG05 is able
to beneficially modulate the balance between TNF-α and IL-10 during innate response, allow-
ing an improved clearance of S. pneumoniae and reducing the inflammatory lung tissue dam-
age at the same time. We found that the TNF-α/IL-10 ratio of BCD+PG06 and BCD+PG534
mice was higher than BCD+PG05 mice, because PG06 does not induce IL-10 production and
PG534 induce higher levels of TNF-α compared with BCD+PG05. These findings had a good
Fig 9. Effect of lactobacilli peptidoglycans on the opsonophagocytic activity of anti-pneumococcal antibodies
after Streptococcus pneumoniae infection in malnourished mice. Immunocompromised-malnourished mice were
replete for 7 days with a balanced conventional diet (BCD) or BCD supplemented with peptidoglycans from
Lactobacillus rhamnosus CRL1505 (BCD+PG05), L. plantarum CRL1506 (BCD+PG06) or L. rhamnosus CRL534 (BCD
+PG534), and then challenged with S. pneumoniae. The opsonophagocytic activity of antibodies were studied fifteen
days after the pneumococcal challenge. Results represent data from three independent experiments. Results are
expressed as mean ± SD. Asterisks represent statistical differences compared with BCD+PG05 group.  p< 0.05, 
p< 0.005,  p 0.001.
https://doi.org/10.1371/journal.pone.0194034.g009
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correlation with lung histopathological studies that revealed significantly higher infiltration of
inflammatory cells and tissue damage in the lungs of these groups when compared to the BCD
+PG05 and BCD groups. We speculate that other cytokines and chemokines of innate
response, as IL-1β, KC, MCP-1 [35–37], produced by lung epithelial cell or alveolar macro-
phages would be involved. Herrera et al., [11] demonstrated that the CRL1505 strain was able
to modulate the CXCL12/CXCR4 axis. Even more, this cytokine balance induced by PG05 is
also responsible for the increase of lung phagocytic cell number, but also the blood peroxidase
activity and the spleen macrophages number.
Pneumococcal exposure can lead to the generation of both T cell and B cell immune
responses to polysaccharide and protein antigens [38,39]. In this work, we evaluate the effect
of PGs treatments on the number and function of effector cells and mediators of adaptive
immune response against to this respiratory pathogen. Malnutrition severely affects T popula-
tion in the bone marrow, thymus, spleen and lung [12,22,40]. The recovery of T cells is impor-
tant for the protection of the host through the production of divers cytokines that control and
coordinate several immune effector mechanisms and their capacity to influencing antibody
production by B cells. In this way, the nasal administration of the CRL1505 strain reduces
quantitative and qualitative alterations of CD4 T cells in recovering malnourished mice [10].
In the current study, BCD+PG05 mice showed a higher number of double negative CD25
+ and double positive T cells after infection than those of others groups, indicating an active
thymopoiesis [41]. These findings are probably related to the increase of CD4 simple positive
cells, observed only in this group. In addition, to promoting the development of CD4 T cells in
the thymus after the pneumococcal challenge, the PG05-treatment managed to increase the
spleen CD3+CD4+ population, and maintain the values of lung CD3+CD4+cells higher than
the other groups. This effect of PG05 agree with the effects induced by viable L. rhamnosus
CRL1505 and could be key to the protection against S. pneumoniae infection [12,42].
Additionally, only the PG05 treatment was able to modulate cytokine production in
response to respiratory S. pneumoniae challenge. It is known that under inflammatory condi-
tions, cytokines in the airways environment change dramatically. When a Th2 response is
needed, there is a production of IL-4, IL-5, and IL-6, which contributes to stimulate B cells to
proliferate and mature into antibody producing cells [43]. Here we found a significant up-reg-
ulation in BAL and serum Th2-cytokine IL-4 in malnourished mice fed with BCD+PG05 after
pneumococcal infection, unlike PG06 or PG534 treatments. This is consistent with the
enhancement of BAL and serum IgA, IgG and IgM anti-pneumococcal production observed
in this group and, is in line with previous reports [10,44]. On the other hand, PG05 treatment
induced the greatest increase of IL-10 in BAL after pneumococcal infection, which could be
associated to the reduction of tissue damage and recruitment of neutrophils to the airways
observed in this group [45]. Even more, only PG05 induced production of IL-2, which partici-
pates in CD4+ T-cell response against pneumococcal antigens [46].
Regarding the impairment of the humoral immune response in malnourished hosts men-
tioned above, we demonstrated that protein malnutrition remarkably reduces BAL and serum
anti-pneumococcal antibodies [8,10]. Moreover, the opsonophagocytic activity of IgG anti-
bodies was significantly reduced in malnourished mice [10]. These findings are associated
with the impairment of B cell population in bone marrow without affecting their capacity to
produce antibodies [10,22]. In the present work, we demonstrated that malnourished mice
treated with PG05 were able to mount a normal immune response against the respiratory
infection. In fact, the increase of bone marrow and lung immature and mature B cells, and
splenic mature B lymphocytes were found in the BCD+PG05 group. These results are associ-
ated with the highest local and systemic anti-pneumococcal antibody production induced with
BDC+PG05 group. Moreover, the PG extracted from probiotic CRL1506 strain induced an
Unique immunomodulatory properties of L. rhamnosus CRL1505 peptidoglycan
PLOS ONE | https://doi.org/10.1371/journal.pone.0194034 March 8, 2018 17 / 21
increase of lung mature B cells, which is related with the levels increased of IgG in BAL. Our
results also showed that BCD+PG534 treatment had no beneficial effect on number or activity
of B cells.
In this point, it is necessary to emphasize that PG06 would not be involved in the immuno-
modulatory properties of viable L. plantarum CRL1506. This finding is in line with our previ-
ous observations. As it was mentioned above, nasally administered viable CRL1506 and
CRL1505 strains improve protection against RSV infection. However, when lactobacilli were
heat-treated, only L. rhamnosus CRL1505 retained its capacity to improve respiratory antiviral
immunity [29]. This observation indicates that viability is a necessary condition for the benefi-
cial effects of L. plantarum CRL1506 that cannot be obtained with non-viable lactobacilli or its
peptidoglycan. Another key difference in immunomodulatory ability of L. plantarum
CRL1506 and L. rhamnosus CRL1505, is the capacity of the CRL1505 strain, when orally
administered, to improve immunity in distal mucosal sites such as the respiratory tract, an
effect that is not achieved by the CRL1506 strain [26,47]. Some research works demonstrated
that the gut microbiome provide signals to sustain immune defense mechanisms in the respi-
ratory tract allowing efficient effector responses upon challenge by pathogens [48,49]. It has
been proposed as a mechanism for distal modulation that respiratory and peripheral immune
cells are directly exposed to bacterial products released in the gut. There is evidence that bacte-
rial molecules from gut microorganisms such as peptidoglycan can be absorbed and circulate
throughout the host allowing the modulation of distal immune cells [49]. In this regard, Ichi-
nohe et al. [48] showed that bacterial products from gut commensals stimulate immune cells
systemically and that factors released by those cells improve the immune response to influenza
virus infection. Therefore, it is likely to speculate that when L. plantarum CRL1506 and L.
rhamnosus CRL1505 are orally administered, the adverse conditions of the gastrointestinal
tract induce the release of bacterial molecules including peptidoglycan that can be absorbed,
circulate, and influence in distal immune cells. However, because PG05 preserves the immu-
nomodulatory properties of viable bacteria while PG06 does not, only L. rhamnosus CRL1505
influence in distal mucosal sites. This hypothesis opens an interesting topic for future
investigations.
Conclusions
In the present study, we demonstrated that dietary recovery of malnourished mice with nasal
administration of peptidoglycan from L. rhamnosus CRL1505 improves not only the innate
immune response but the respiratory and systemic adaptive immune response as well. Then,
we demonstrated for the first time that peptidoglycan from L. rhamnosus CRL1505 preserves
the complete immunomodulatory properties of viable bacteria. In addition, by performing
comparative studies with the peptidoglycan from L. plantarum CRL1506, an immunomodula-
tory bacterium, we consider that peptidoglycan from L. rhamnosus CRL1505 has unique
immunomodulatory properties that could not be extended to peptidoglycans from other
immunobiotic strains. The knowledge of the molecular characteristics of PG05 is indispens-
able to understand immunomodulatory abilities of L. rhamnosus CRL1505.
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